What is PHIO stock price today?

Visit our real-time dashboard for the current PHIO stock price and live market data.

Is PHIO stock going up or down today?

PHIO stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy PHIO stock now?

The decision to buy PHIO depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is PHIO a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for PHIO based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is PHIO stock overvalued or undervalued?

Use our DCF valuation calculator to determine if PHIO is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is PHIO's P/E ratio?

P/E ratio data for PHIO will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is PHIO's market cap?

PHIO (Phio Pharmaceuticals Corp) has a market capitalization of $0.01 billion, making it a small-cap stock.

What is PHIO's price to book ratio?

Price-to-book ratio for PHIO is available on our dashboard along with other valuation metrics.

Does PHIO pay dividends?

PHIO does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is PHIO's dividend yield?

PHIO does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is PHIO stock a good long-term investment?

PHIO's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is PHIO's revenue growth rate?

Revenue growth data for PHIO is available on our dashboard with detailed financial statement analysis.

Profitability metrics for PHIO are available on our dashboard with complete income statement analysis.

What are the risks of investing in PHIO?

Key risks for PHIO include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does PHIO compare to its competitors?

Compare PHIO to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize PHIO's performance and positioning.

What is PHIO's stock price target for 2026?

Visit our prediction page for AI-powered price targets for PHIO with bull, base, and bear case scenarios.

What do analysts say about PHIO?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for PHIO. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is PHIO's next earnings report?

PHIO reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

PHIO - Phio Pharmaceuticals Corp

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+0.00%)

About Phio Pharmaceuticals Corp

Phio Pharmaceuticals Corp (PHIO) common stock

Price Chart

Loading chart...

PHIO Key Statistics

Market Cap

$10.41M

How PHIO Compares to Peers

PHIO is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
PHIO(This stock)	$10.41M	N/A	0%	0.0%	-
AMGNAmgen Inc	$188.67B	24.3	0%	0.0%	vs AMGN
GILDGilead Sciences	$160.15B	17.5	0%	0.0%	vs GILD
VRTXVertex Pharmaceuticals	$106.87B	29.7	0%	0.0%	vs VRTX
REGNRegeneron Pharmaceuticals	$59.10B	13.9	0%	0.0%	vs REGN
BIIBBiogen Inc	$29.33B	21.4	0%	0.0%	vs BIIB

Data Updated: July 16, 2026 at 6:58 PM EDT

Ready to invest in PHIO?

Commission-free trading available. Affiliate links.

PHIO Lician Score

5% confidence

4.0/10

Neutral

PHIO has a Lician Score of 4/10 (Average). Areas of concern: Growth.

value

5.0

growth

2.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates PHIOacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

PHIO Financial Snowflake

5-axis analysis across key investment dimensions

4.4/10

Neutral

5.0

Value

Valuation vs. sector peers

2.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for PHIO

Dashboard

Enter a ticker to analyze